Home » Topics » BioWorld Science

BioWorld Science
RSS

Rapt Therapeutics studies oral CCR4 antagonist RPT-193 in first-in-human trial

Oct. 24, 2019

Microbio constructs aptamer targeting LAG-3 for cancer immunotherapy

Oct. 24, 2019

Enanta Pharmaceuticals describes new HBV antivirals

Oct. 24, 2019

Agios Pharmaceuticals synthesizes new MAT2A inhibitors

Oct. 24, 2019

Neuropore Therapies identifies TLR2 antagonists

Oct. 24, 2019

Emory University discloses ionotropic glutamate GluN2C/D receptor antagonists

Oct. 24, 2019

Arvinas presents initial data for its PROTAC targeted protein degraders

Oct. 24, 2019

PTC Therapeutics patents compounds for Huntington's disease

Oct. 24, 2019

Arecor announces a joint research, development and commercialization agreement with JDRF

Oct. 24, 2019

Biomica, Weizmann Institute of Science to develop treatment for antibiotic-resistant bacteria

Oct. 24, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...